At Astellas, we strive to be a cutting-edge, value-driven life science innovator. This means working at the forefront of healthcare change to turn innovative science into the best outcomes for patients. Operating in approximately 70 countries with more than 14,000 employees, we are relentless in our...See more
Headquarter Japan |
Year founded 2013 (11 years) |
Funding status Publicly listed on stock exchange |
Company type MNC / Large Enterprise |
Head of Sales
Head of Commercial Communications, Global Markets
Business Unit Head Sin Mal
The company has a sophisticated ownership structure and may be part of a large corporate group
The company's annual budgeting is likely to take place between January - March
Job title | Name | Email | Country based in | Job Function | Seniority | |
---|---|---|---|---|---|---|
Head of Sales | hidden.item | hidden.item | hidden.item | |||
Head of Commercial Communications, Global Markets | hidden.item | hidden.item | hidden.item | |||
Business Unit Head Sin Mal | hidden.item | hidden.item | hidden.item |
Fiscal/Budgeting Period: | January - March |
Auditor: | ERNST & YOUNG LLP |
Corporate-only access Contact us for a free demo now! | |
Sign up to view for free |
Company | Incorporation date | Country of Registration | Share capital | Local SIC |
---|---|---|---|---|
| 1 Jul 2013 | Singapore | SGD 2,000,000 | 46461: WHOLESALE OF MEDICINAL AND PHARMACEUTICAL PRODUCTS (WESTERN) |